DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair, With death on the horizon, nothing will not stop me except God................DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 25Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK GENERICS at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contribution

Tuesday 23 December 2014

31P spectrum

Gyroscope precession
 
 
This is the 31P spectrum. The scale is Hz. This spectrum shows the expected septuplet pattern of peaks having integrated intensities of 1:6:15:20:15:6:1 resulting from the splitting of the phosphorous atom by the six equivalent I=1/2 19F nuclei. The coupling constant, JPF was found experimentally to be 714 Hz, very similar to the value listed above.

The 19F and 31P FT-NMR Spectra
This is the Free Induction Decay Curve for the 19F spectrum.
This is the 19F spectrum. The scale is Hz. This spectrum shows the expected doublet pattern of peaks having equal integrated intensities resulting from the splitting of the six equivalent flourine atoms by the I=1/2 31P nucleus. The coupling constant, JPF was found experimentally to be 717 Hz.
This is the 31P spectrum. The scale is Hz. This spectrum shows the expected septuplet pattern of peaks having integrated intensities of 1:6:15:20:15:6:1 resulting from the splitting of the phosphorous atom by the six equivalent I=1/2 19F nuclei. The coupling constant, JPF was found experimentally to be 714 Hz, very similar to the value listed above.
The Vibrational Spectrum
This vibrational spectrum was calculated by Hyperchem. The vibrations predicted by Hyperchem are at (in cm-1): 219, 376, 470, 851, 974, and 1292. These correspond to the following examples of normal modes of vibration (in respective order):
v6 (t2u)                                            v5 (t2g
v4 (t1u)                                             v2 (eg
v1 (a1g)                                          v3 (t1u
In comparison with literature values from Kazuo Nakamoto's Infrared and Raman Spectra of Inorganic and Coordination Compounds; 5th ed.; Part A; page 216, these vibrations are at (in cm-1): not available, 480~468, 559;530, 585;570, 756, and 865;835. Note the splitting of three of the spectral lines. It appears that many Hyperchem lines were calculated higher than the experimental values. This is consistent with the nature of these semi-empirical calculations (AM1). The symmetry labels above were obtained through comparison of the Hyperchem normal modes with those found in Nakamoto, p. 215. These modes were found by Hyperchem to be triply degenerate with the exceptions of v3 (t1u) and v1 (a1g) which were doubly and nondegenerate, respectively.
The Electronic Spectrum
This electronic spectrum of the singly excited state was calculated by Hyperchem. Note that all transitions are deep in the UV.
DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO .....FOR BLOG HOME CLICK HERE

Join me on Linkedin

View Anthony Melvin Crasto Ph.D's profile on LinkedIn

Join me on Facebook FACEBOOK
Join me on twitterFollow amcrasto on Twitter     
Join me on google plus Googleplus

 amcrasto@gmail.com

Acetonide








with 2.2 g of the p-nitrophenyl glycoside, 50 mL of 1,4-dioxane, 8 mL of 2,2-dimethoxypropane and 75 mg of TsOH.





DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO .....FOR BLOG HOME CLICK HERE

Join me on Linkedin

View Anthony Melvin Crasto Ph.D's profile on LinkedIn

Join me on Facebook FACEBOOK
Join me on twitterFollow amcrasto on Twitter     
Join me on google plus Googleplus

 amcrasto@gmail.com




vietnam

Map of vietnam country.


 Image result for vietnam



 
 

 
 

 

 dalat city
hanoi











//////////

Protection of Acetol as THP ether

Protection of Acetol as THP ether



 

Protection of Acetol as THP ether

 

Literature References

  1. Xiao, Y.; Liu, P. Angew. Chem. Int. Ed. 2008, 47, 9722-9725.
    • See the supplemental material for a "Synthesis of acetonyl tetrahydropyranyl ether (17)".
  2. Sondheimer, F.; Stjernstrom, N.; Rosenthal, D. J. Org. Chem. 1959, 24, 1280-1284.
    • Look for the experimental for "Acetol 2'-tetrahydropyranyl ether (VIIIb)". Interestingly, they say that the material was stored at -10 degrees C, or used directly for the next step since it decomposed on standing at room temperature!
  3. Hagiwara, H.; Uda, H. J. Chem. Soc., Perkin-I 1984, 91.
  The literature listing for the NMR (Xiao reference above) is 1H-NMR (CDCl3, 400 MHz): 4.64 (t, J = 3.6 Hz, 1 H), 4.26 (d, J = 17.6 Hz, 1 H), 4.12 (d, J = 17.6 Hz, 1 H), 3.81-3.86 (m, 1 H), 3.49-3.54 (m, 1 H), 2.18 (s, 3 H), 1.61-1.89 (m, 6 H).









 DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO .....FOR BLOG HOME CLICK HERE

Join me on Linkedin

View Anthony Melvin Crasto Ph.D's profile on LinkedIn

Join me on Facebook FACEBOOK
Join me on twitterFollow amcrasto on Twitter     
Join me on google plus Googleplus

 amcrasto@gmail.com


Ketal


.............


 
 
 

Literature References

  1. Cornish, C.A.; Warren, S. J. Chem. Soc. Perkin Trans. I 1985, 2585. "Synthesis of Single Isomers (E or Z) of Protected gamma,delta-Unsaturated Ketones by the Horner-Wittig Reaction"
    • This article has procedures for the conversion of acetylbutyrolactone into the chloro, bromo, and iodo-pentanones, along with their subsequent conversions to the ethylene ketals.
  2. Bellas, T.E.; Brownlee, R.G.; Silversteing, R.M. Tetrahedron 1969, 25, 5149. "Synthesis of Brevicomin, Principal Sex Attractant in the Frass of the Female Western Beetle"
    • This article has an experimental for the conversion of acetylbutryolactone into 5-bromo-2-pentanone (1) and then conversion of this to ketal 2.










DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO .....FOR BLOG HOME CLICK HERE

Join me on Linkedin

View Anthony Melvin Crasto Ph.D's profile on LinkedIn

Join me on Facebook FACEBOOK
Join me on twitterFollow amcrasto on Twitter     
Join me on google plus Googleplus

 amcrasto@gmail.com



WO2011069761

 Figure imgf000037_0001






Example 2
2-(Difluoromethyl)-4-(6-fluoro-3-methyl-lH-indazol-5-yl)-6-(4-fluorophenyl)-l,4-dihydropyridine- 3,5-dicarbonitrile
A mixture of 200 mg (0.569 mmol) (2ii)-2-(4-fluorobenzoyl)-3-(6-fluoro-3-methyl-lH-indazol-5-yl)- prop-2-enenitrile (Example 5A) and 69 mg (0.569 mmol) 3-amino-4,4-difluorobut-2-enenitrile [obtainable by Thorpe reaction of acetonitrile with 2,2-difluoroacetonitrile, cf. Org. React. 15, 1 (1967), ibid. 3J_, 1 (1984)] in 2-propanol (1 ml) was stirred at reflux for 12 h. Then, acetic acid (1.5 ml) was added, and stirring at reflux was continued for 6 h. Upon cooling, the mixture was concentrated under reduced pressure, and the residue was directly purified by preparative RP-HPLC (methanol/water + 0.1 % TFA gradient, final mixture 80:20 v/v) to yield 36 mg (15% of th.) of the racemic title compound. LC-MS (method 4): Rt = 0.97 min; MS (ESIpos): m/z = 424 (M+H)
'H-NMR (400 MHz, DMSO-dg): δ = 12.87 (br. s, 1H), 10.44 (s, 1H), 7.78 (d, 1H), 7.61 (m, 2H), 7.41-7.35 (m, 3H), 6.79 (t, 1H, F = 51.8 Hz), 5.08 (s, 1H), 2.54 (s, 3H) ppm.


 http://www.google.com/patents/WO2011069761A1?cl=en

 


Comparative Example B
2-(4-Fluorophenyl)-6-methyl-4-(3-methyl-lH-indazol-5-yl)-l,4-dihydropyridine-3,5-dicarbonitrile

A mixture of 200 mg (0.89 mmol) (2i?)-2-[(3-methyl-lH-indazol-5-yl)methylidene]-3-oxobutane- nitrile (Example 2A), 159 mg (0.98 mmol) 3-(4-fluorophenyl)-3-oxopropanenitrile and 205 mg (2.66 mmol) ammonium acetate in ethanol/acetic acid (4: 1 v/v, 1 1 ml) was heated to reflux overnight. After cooling, the reaction mixture was directly purified by preparative RP-HPLC (acetonitrile/water + 0.1% TFA gradient) to afford 136 mg (41% of th.) of the racemic title compound.
LC-MS (method 2): Rt = 1.04 min; MS (ESIpos): m/z = 370 (M+H)+
'H-NMR (400 MHz, DMSO-dg): δ = 12.70 (br. s, 1H), 9.74 (s, 1H), 7.64-7.59 (m, 3H), 7.53 (d, 1H), 7.40-7.33 (m, 3H), 4.68 (s, 1H), 2.48 (s, 3H), 2.11 (s, 3H) ppm.










DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO .....FOR BLOG HOME CLICK HERE

Join me on Linkedin

View Anthony Melvin Crasto Ph.D's profile on LinkedIn

Join me on Facebook FACEBOOK
Join me on twitterFollow amcrasto on Twitter     
Join me on google plus Googleplus

 amcrasto@gmail.com